skip to content

Roche’s Half Year Results 2021

Roche has published its Half Year Results for 2021 prior to the opening of the Swiss Stock Exchange on Thursday, July 22nd 2021.

Agenda:
Overview- Severin Schwan, CEO Roche Group
Pharmaceuticals Division- Bill Anderson, CEO Roche Pharmaceuticals
Diagnostics Division - Thomas Schinecker, CEO Roche Diagnostics
Financial Results- Alan Hippe, Chief Financial and IT Officer
Questions and answers- Karl Mahler, Head of Investor Relations

Webinar Replay

Investors

Past IR Events
View more Events